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from the DCE with and without out-out differed. Results suggest that including 
an opt-out reduces efficiency with respect to power.  
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OBJECTIVES: To empirically test to what extent the layout of choice tasks (i.e., 
displayed in words or graphics) in a Discrete Choice Experiment (DCE) influences 
the attribute estimates and the conclusions drawn from the DCE. METHODS: A 
DCE questionnaire was sent to the parents of 2500 newborn babies aged 6 weeks 
at maximum. Each questionnaire contained two times the same 9 choice tasks, 
ones words were used to describe the attributes and levels and ones graphics 
were used. The DCE consisted of five attributes related to the decision of parents 
to vaccinate their newborn baby against the rotavirus (vaccine effectiveness, 
frequency of severe side effects, protection duration, location, costs). Mixed logit 
models were conducted to estimate the relative importance of the attributes. 
RESULTS: Preliminary results are based on 279 observations from 31 parents. In 
February 2013 data collection will be completed and analyzed. When comparing 
the choices of every respondent per choice tasks, 58% chose inconsistent at 1 or 
more choice tasks and 35% chose inconsistent in two or more choice tasks. In 
both datasets (layout in words and graphics), vaccine effectiveness (βeffects code 
1=0.64 and βeffects code 1=1.00, βeffects code 2=0.67 and βeffects code 2=0.01), frequency of severe 
side effects (βeffects code 1=0.26 and βeffects code 1=0.41, βeffects code 2=1.22 and βeffects code 
2=0.89) protection duration (β=0.37, β=0.17) and costs (β=-0.10, β=-0.11) showed 
significant attribute estimates (P<.05). However, the relative importance of these 
attributes differed between both datasets. CONCLUSIONS: For now it can be 
concluded that the presentation of the choice sets (by either using words or 
graphics) in a DCE influences study outcomes. Besides extensive pilot testing to 
ensure the choice tasks are understood and interpreted as intended, it might be 
worthwhile to include discussions about the layout of the choice tasks in the 
focus group stage of the DCE designing process.  
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OBJECTIVES: Cognitive debriefing is critical to the content validity of patient-
reported outcome (PRO) questionnaires. The goal of this poster is to evaluate the 
time needed to adequately debrief PRO questionnaires and to generate a set of 
questions that could facilitate the timely and successful completion of cognitive 
debriefing interviews. METHODS: To evaluate cognitive debriefing methods, two 
research activities were conducted. First, a time-to-complete analysis was 
conducted using n=44 audio-recorded patient interviews to understand how 
much time was required to debrief single PRO items. Next, select studies (n=15) 
were reviewed to document the researcher stated objectives of their cognitive 
debriefing activities. This list of objectives was used to inform a set of questions 
that could be asked of patients during debriefing to accomplish those objectives. 
RESULTS: The time-to-complete analysis showed that single questionnaire items 
required approximately 5 minutes and 45 seconds to be fully debriefed. Primary 
objectives of cognitive debriefing interviews included the evaluation of a) 
patients’ interpretation of the instructions, items, and response options relative 
to questionnaire developer’s intentions; b) the extent to which item concepts 
assessed in the questionnaire are comprehensive to the general concept of 
measurement; c) item language that reflects patient experience, and d) response 
options as representative of patient health status. CONCLUSIONS: Results 
suggest that it takes approximately 60 minutes to fully debrief a PRO 
questionnaire constructed of 10 items. Though longer interviews are possible, 
interviews lasting longer than 60 minutes may produce data of poor quality due 
to patient fatigue. Therefore, debriefing studies require clearly stated objectives 
along with targeted questions to help the interviewer successfully and efficiently 
meet those objectives. The interview questions discussed in this poster can be 
used by researchers to facilitate the timely and targeted completion of cognitive 
debriefing interviews for the purpose of supporting content validity of a PRO 
questionnaire.  
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OBJECTIVES: Prescription cost-sharing and pill burden may predict duration of 
persistence with antiretroviral therapy (ART) in HIV patients. These predictors 
are correlated and may vary with time, necessitating sophisticated modeling 
approaches to generate unbiased and consistent estimates of their effects on 
ART persistence. This analysis compared the estimated effect of ART cost-
sharing on ART persistence when adjusting for ART pill burden through 
traditional time-dependent Cox versus newer marginal structural modeling 
(MSM) approaches. METHODS: Retrospective observational cohort study using a 
large U.S. claims database. Subjects were commercially-insured antiretroviral-
naïve HIV patients initiating ART during the period January 1, 2003 to December 
31, 2007. ART persistence was measured as the number of days from ART 
initiation until addition of a new antiretroviral, 30-day gap in possession of an 
initiated antiretroviral, or censoring at loss to follow-up. During the period of 
persistence, ART cost-sharing per 30-day supply of the ART regimen and daily 
average ART pill burden were measured within a patient-quarter repeated-
measures panel dataset. Time-dependent Cox and MSM approaches were 
compared with respect to their estimated effect of ART cost-sharing (>$50 versus 
≤$50) on ART persistence. MSM was implemented using inverse probability of 
treatment weights within a weighted Cox model with generalized estimating 
equations. RESULTS: Sample comprised 3,731 patients producing 19,199 patient-
quarters: mean age=41.1 years; male=83.2%; median ART cost-sharing=$40; 
median ART pill burden=3.2. Using time-dependent Cox modeling, ART cost-
sharing >$50 (versus ≤$50) was estimated to be not significantly associated with 
ART persistence (Hazard Ratio [HR]=0.96, 95% confidence interval [CI]=0.78-1.18, 
p=0.733). In contrast, using MSM, ART cost-sharing >$50 was estimated to be 
significantly associated with shorter durations of ART persistence (HR=1.28, 95% 
CI=1.16-1.43, p<0.001). CONCLUSIONS: Appropriate model choice is critical in the 
presence of complex relationships between correlated time-varying predictors 
and outcomes. Using MSM, ART cost-sharing >$50 was found to be significantly 
associated with shorter durations of ART persistence.  
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OBJECTIVES: Medicare has announced plans to include efficiency measures in 
the End-Stage Renal Disease Quality Incentive Program. Few studies have 
analyzed US dialysis center efficiency, despite ongoing payment incentives to 
deliver dialysis care more cost-effectively. The objective of this study was to 
assess overall dialysis center efficiency as well as the impact of anemia drug 
choice on efficiency. METHODS: Using 2010 data from Medicare Renal Cost 
Reports, a data envelopment analysis (DEA) was performed to model the 
technical efficiency of 4,343 free-standing dialysis centers. DEA uses a linear 
programming technique that converts multiple inputs (costs, staffing levels) and 
an output measure (number of dialysis sessions) to a relative efficiency score 
between 0 and 1, where scores are proportional to the efficiency frontier (score of 
1.0.) A second DEA was conducted to assess changes in score distribution if labor 
and supply cost inputs were reduced due to switching to less frequent dosing of 
anemia drugs. Regression analysis was performed to account for variations in 
organizational and environmental conditions. RESULTS: About 78% of facilities 
were owned by the two largest chains. Nearly 93% of facilities were for-profit; 
75% were in urban areas. 33% of facilities were functioning efficiently (efficiency 
scores ≥.90); 30% had scores between .70 and .90, and 37% scored <.70. Neither 
the intensity of market competition nor the profit status of the facility had a 
significant effect on efficiency. Facilities that were members of large chains were 
less likely to be efficient. Cost and labor savings due to changes in drug protocols 
had little effect on overall dialysis center efficiency. CONCLUSIONS: 
Opportunities exist for continued improvements in the efficiency of US dialysis 
facilities. DEA may be a useful tool for evaluating dialysis center efficiency. 
Future studies should incorporate quality of care dimensions and case-mix 
adjustment in the measurement of efficiency.  
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OBJECTIVES: Network meta-analysis is a relatively new statistical approach for 
synthesizing evidence. Network meta-analysis includes both ‘‘direct’’ and 
‘‘indirect’’ comparisons to strengthen inference concerning the relative efficacies 
of treatment pairs. Further, the approach facilitates simultaneous inference 
regarding all treatments, allowing the ranking of therapeutic options by 
effectiveness. This study reviewed published network meta-analyses pertaining 
to pharmaceuticals, and identified trends in the literature. METHODS: Using the 
PubMed electronic database, we performed a systematic search using the 
following terms; “network meta-analysis”, “mixed treatment comparison”, and 
“indirect treatment comparison”. Two reviewers assessed each study. We 
excluded studies that did not include pharmaceuticals or biologics, pertained to 
methods, did not report efficacy endpoints, or were not published in English. For 
each study we reported publication year, funding source (industry or non-
industry), disease type, and whether the study included a biologic treatment. 
RESULTS: A total of 142 of the 288 abstracts identified through the systematic 
search were included. Over time, there has been a rapid growth in the literature, 
with nine studies published between 1997 and 2008, 14 in 2009, 18 in 2010, 38 in 
2011, and 63 in 2012. The majority of studies were non-industry funded (55.6%). 
Drugs for musculoskeletal and rheumatic disease were the most frequently 
evaluated (22.5%), followed by drugs for cardiovascular disease (14.8%), cancer 
(11.3%), e.g., breast cancer and lung cancer, and infectious disease (11.3%), and 
psychiatric and neurological conditions (10.5%). A total of 35.9% of studies 
included at least one biologic. CONCLUSIONS: The number of published network 
meta-analyses is growing rapidly. Studies are performed across a range of 
